Southeast Asia is entering a new investment cycle, but Thailand stands out due to a highly orchestrated, state-led industrial transformation. Many professionals still view regional expansion merely as a pursuit of cheap labor, but the reality of the Thailand 4.0 investment 2026 landscape demands a different approach. This initiative is not just economic branding; it […]
Vietnam’s markets for pharmaceuticals and dietary supplements are expanding rapidly, attracting significant investment focused on health and wellness. However, this growth comes with substantial quality-related risks.
For investors, a lapse in product quality is not just a compliance issue; it’s a direct threat to financial performance, market reputation, and consumer safety. Understanding the distinct responsibilities of each stakeholder in managing drug and supplement quality is critical for mitigating these risks. Many consumers rely on these products to stay healthy, making robust quality control essential for overall health.
With a track record supporting multinational corporations, our team has seen how robust compliance frameworks reduce financial losses and streamline licensing.
Navigating Vietnam’s key governing regulations, including the Vietnamese Pharmacy Law, is the foundation of a successful investment strategy for any supplement company.
Key Takeaways:
- Regulatory Oversight is Multi-Layered: Investors must engage with several authorities, including the Ministry of Health (MOH) and Vietnam Food Administration (VFA), each with specific mandates for drugs and dietary supplements.
- Manufacturer and Importer Liability is Absolute: Companies are responsible to adhere to GMP standards, including mandatory batch testing, raw material verification, and maintaining comprehensive quality documentation.
- Supply Chain Integrity is Non-Negotiable: Distributors and retailers share responsibility for quality, requiring strict compliance with storage standards, anti-counterfeiting measures, and traceability to protect investors from downstream risks.
- A Dual-Track Compliance Model is Essential: Drugs and health supplements are governed by different regulations in Vietnam, demanding separate compliance strategies to manage risk effectively.
- Proactive Compliance is a Financial Strategy: Viewing quality control as a core financial strategy, rather than just a legal requirement, allows supplement companies to prevent costly recalls and reputational damage.
Understanding the Responsibilities of Regulatory Authorities
Navigating Vietnam’s regulatory environment requires a clear understanding of how different agencies coordinate. The local regulatory requirements can be complex. Our experience has shown that proactive communication with these bodies can significantly reduce project delays.
Ministry of Health (MOH) and Drug Administration of Vietnam (DAV)
The MOH and its executive body, the DAV, are the primary regulators for pharmaceuticals. They oversee market authorization and set quality standards. According to an analysis by Viet An Law (2024), the Law on Pharmacy 2016 (as amended by Law No. 44/2024/QH15) streamlines registration procedures to improve patient access to medicines while maintaining stringent quality controls. These regulations determine the approval lifecycle for all medications.
Vietnam Food Administration (VFA) for Supplements
The VFA is the key authority for dietary supplements, with a role similar to the Food and Drug Administration (FDA) in other countries. It focuses on post-marketing surveillance, product claims, and contaminant standards for foods and supplements. According to a Tilleke & Gibbins report (2024), the recently issued QCVN 20-1:2024/BYT is Vietnam’s first national technical regulation setting limits for contaminants like heavy metals in health supplements. The VFA is vigilant about label claims, and investors should be aware that marketing violations are a high risk.
General Department of Market Surveillance (GDMS)
Often overlooked, the GDMS plays a vital role in protecting market integrity. This body is responsible for enforcement against counterfeit and substandard products, including dietary supplements that could be potentially dangerous. Its activities are crucial for maintaining a level playing field for legitimate manufacturers.
Provincial Departments of Health (DOH)
Provincial DOH teams are the on-the-ground enforcers, conducting on-site inspections and sample testing. They coordinate with other agencies for escalated cases. Proactive engagement with these teams helps ensure compliance.
Manufacturer and Importer Responsibilities for Quality Compliance

Legal standards must be translated into actionable investor checklists. Foreign investors must ensure their targets and operations meet Vietnam's stringent quality compliance mandates for any dietary supplement.
Adherence to GMP, GLP, GSP, and Testing Protocols
Manufacturers must comply with Good Manufacturing Practices (GMP). As detailed in a key guidance document, Circular 30/2025/TT-BYT, the entire manufacturing process must be validated. An analysis by LuatVietnam (2025) highlights that this circular enforces strict guidelines for the testing of drugs and medicinal materials. For due diligence, investors should demand to see all quality control reports.
Raw Material Quality Control
For dietary supplements, controlling the quality of each dietary ingredient is paramount. This includes verifying the purity of vitamins like Vitamin C and Vitamin D, minerals such as calcium, and other nutrients like amino acids.
Supplement manufacturers must ensure no raw materials contain harmful levels of contaminants. The chemical makeup of all supplement ingredients must be thoroughly tested.
Importer-Specific Obligations
Importers carry the responsibility of verifying that each dietary supplement conforms to registered specifications. This includes checking the active ingredients listed on the product label. Any discrepancy can trigger forced recalls and financial penalties.
Governance and Reporting for M&A Due Diligence
During M&A, investors must scrutinize a target’s compliance maturity. Critical documents include recall histories and GMP inspection results from facilities. Research from bodies like the National Institutes of Health can provide context on the benefits and risks of certain supplement ingredients.
Distributor and Retailer Responsibilities in the Quality Chain
Quality control does not end at the factory gate. The supplement industry relies on a secure supply chain.
Storage and Distribution Compliance
Distributors must adhere to Good Distribution Practices. A compliance failure can render a high-quality supplement unsafe, exposing investors to reputational and financial damage.
Anti-Counterfeit and Traceability Measures
To combat counterfeit products, robust traceability systems are needed. Before investing, a thorough evaluation of a target’s supply chain integrity is essential to ensure products are secure.
Retailer Responsibilities
Retailers are the final guardians of product quality. They are required to avoid misleading marketing claims on any dietary supplement label and sell only products with a lawful origin.
They should not treat a supplement as a cure for conditions like heart disease without proper evidence. A consumer should always consult their doctor before taking high doses of any new vitamin or mineral.
An Action Plan for Investors
Successfully navigating Vietnam’s quality landscape requires a proactive stance that integrates quality management into core financial and strategic planning.
Transformative Insight 1: Quality Compliance is a Financial Strategy
Viewing compliance as a cost center is a mistake. The upfront investment in robust testing and supplier audits is minimal compared to the staggering costs of a recall. The goal is to ensure compliance with all food and drug regulations.
Transformative Insight 2: Vietnam Requires a Dual-Track Compliance Model
Drugs and health supplements operate under distinct regulatory frameworks. Successful investors structure their compliance teams to reflect this reality, drawing on principles from global standards, such as those that influenced the Dietary Supplement Health and Education Act.
Investor-Focused Compliance Checklist
- For M&A: Evaluate the target's recall history and CAPA system. For products making strong health claims, review any supporting clinical trials.
- For Greenfield Projects: Design GMP-compatible infrastructure from day one to streamline the manufacturing of supplements.
- For Distribution Networks: Assess risk by tiering distributors based on their compliance maturity and ability to handle various product form factors.
What Investors Should Do Next
In Vietnam's health sector, understanding these responsibilities is a decisive strategic advantage. Investors who master this landscape are better positioned to protect their capital and achieve sustainable growth in the dietary supplements market.
The next steps are clear. Investors should conduct a thorough regulatory review, develop a dual-track testing strategy for their supplements, and rigorously evaluate all suppliers. As a trusted advisory firm, we encourage investors to prioritize a proactive and deeply informed compliance strategy to unlock the full potential of this dynamic market.
Frequently Asked Questions
What are the biggest compliance risks for foreign investors in Vietnam's supplement market?
The most significant risks are misleading label claims and failing to meet contaminant limits in dietary supplements. The Vietnam Food Administration (VFA) actively penalizes companies for making unsubstantiated health claims on packaging. A supplement found with potentially dangerous contaminants can lead to forced recalls.
How long does it typically take to get a new drug registered under the updated Pharmacy Law?
While the revised law aims to streamline processes, timelines vary. For standard applications, the process can take 12-24 months. It is intended to ensure all medications are safe and effective. An applicant must adhere to all regulatory requirements.
For an M&A deal, what are the top three red flags in a target company's quality management system?
The top three red flags are an incomplete recall history, a weak Corrective and Preventive Action (CAPA) system, and inconsistent quality control records. A missing recall history suggests a lack of transparency, and messy audit logs point to a weak compliance culture, posing significant post-acquisition risks. Any reputable dietary supplement manufacturer, such as those certified by NSF International, will have these records in order.
You may also like: MedTech Industry Development in Vietnam: Opportunities and Challenges











